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Maternal anaemia and folate intake in early pregnancy
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Background The World Health Organization recommends that women take 400 µg of folate supplementation daily throughout pregnancy.
We examined the relationship between total folate intake from the diet and supplements at the ﬁrst prenatal visit and haematological indices at
this visit and subsequently.
Methods Women were recruited at their convenience and in addition to clinical and sociodemographic details, detailed questionnaires on
dietary intakes and supplementation consumption were completed under supervision. A full blood count and serum and red blood cell (RBC)
folate levels were taken.
Results Of the 502 women studied, 97.5% had inadequate total dietary folate intake at the ﬁrst visit, but, 98.2% were taking folic acid (FA)
supplementation. Only 1.8% (n = 9) had anaemia at their ﬁrst visit (with no case of macrocytosis). Subsequently, 212 women had a further Hb
sample in the third trimester and 8.5% (n = 18) were anaemic and 43.4% (89/205) were anaemic postnatally. There was a relationship
between the development of anaemia postnatally and lower RBC folate levels at the ﬁrst visit (P = 0.02).
Conclusions In a country where FA food fortiﬁcation remains voluntary, these ﬁndings support the recommendation that women should start
FA supplementation before pregnancy and continue FA after the ﬁrst trimester.
Keywords anaemia in pregnancy, folic acid supplementation

Introduction
The associations between maternal anaemia and an increase in
maternal and foetal mortality and morbidity are well established, particularly in the developing world.1,2 Anaemia is more
likely to develop as pregnancy advances due to increasing fetomaternal cellular requirements and physiological changes in
folate metabolism. To adjust for haemodilution during pregnancy, anaemia may be deﬁned as a haemoglobin <11.0 g/dL
in the ﬁrst trimester, <10.5 g/dL in the second and third trimesters and <10.0 g/dL postnatally.3,4
The prevalence of anaemia in pregnancy varies widely due
to the variation in maternal dietary intakes of micronutrients
and in the consumption of supplementary vitamins. In pregnant women, the prevalence of anaemia was 6.1% in the
USA, 18.7% in Europe and 55.8% in Africa with inadequate
iron intake the commonest cause.5 As iron deﬁciency may
result in a microcytic anaemia, it is recommended by the
World Health Organization (WHO) that in regions with a
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high prevalence of anaemia, all pregnant women should take
60 mg of iron during pregnancy to prevent iron deﬁciency
anaemia.6
Inadequate folate intake may result in a macrocytic
anaemia but the recommended nutrient intake values during
pregnancy vary widely between countries.7 In 1991–92, two
landmark RCTs demonstrated that folic acid (FA) supplementation prevents neural tube defects (NTDs). Subsequently,
national recommendations advised women to start FA before
pregnancy and to continue for the ﬁrst trimester.8 Many countries also implemented either voluntary or mandatory FA food
fortiﬁcation policies because periconceptual FA supplementation
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ABSTRACT

MATERNAL ANAEMIA AND FOLATE INTAKE

Materials and methods
We studied women presenting for prenatal care after ultrasound conﬁrmation of an ongoing pregnancy <18 weeks
gestation. The exclusion criteria were women aged <18 years
old and women who could not understand English. Women
were recruited conveniently at their ﬁrst prenatal visit by a
single researcher (SC). Their height and weight were measured before calculating body mass index (BMI). Clinical
and sociodemographic details were computerized as part of
the standard medical records by a trained midwife using a
barcode system.
The women also completed a detailed questionnaire under
supervision which included questions on the duration of FA
use, multivitamin use and the brand and dosage of supplements. Their total dietary intake was calculated using
Nutritics Version 3.7 (University Edition). The dietary data
were compiled based on an average daily intake for each
food listed in a retrospective four day dietary history which
was completed under supervision. Care was taken to specify
particular food brands due to the varying content with
respect to voluntary FA fortiﬁcation.12 Dietary folate equivalent was calculated for the dietary and supplemental intakes

where 1 µg of folate from food is equal to 1 µg DFE. For FA
in fortiﬁed food or supplements 1 µg of FA is equal to 1.7 µg
DFE, as folate from food is 50% bioavailable compared to
85% bioavailability from supplementation (85/50 = 1.7).13
In addition, a routine full blood count was taken and
blood for other biomarkers including plasma folate, whole
blood folate and RBC folate levels. A microbiological assay
was used to measure maternal folate.14
The hospital laboratory results system was searched for
any further full blood count results taken over the course of
the pregnancy and the gestation at phlebotomy recorded (if
multiple samples were taken, the sample with the highest Hb
value from each trimester was recorded). Delivery information was computerized under midwifery supervision immediately after birth before discharge from the delivery suite.
Data was anonymized and coded in SPSS (IBM SPSS
Statistics version 20). Continuous data were assessed for
normality by visual inspection of the histogram and box-plot
and calculation of kurtosis and skewness. Descriptive statistics were used to describe the characteristics of the study
population and where necessary, continuous variables were
recoded into categorical variables for further analysis.
Independent samples t-test was used to assess the difference
between the mean Hb in the third trimester according to
prepregnancy folic use. Linear regression was used to assess
for relationships between prepregnancy folic acid use and
duration of use and RBC folate levels at the ﬁrst prenatal
visit and Hb at term. Multiple regression was performed to
control for potential confounding factors where necessary.
Tests for statistical signiﬁcance were performed with signiﬁcance set at the 95% level.
Approval was granted by the Hospital’s Research and
Ethics Committee and written consent was obtained.

Results
The characteristics of the study population are shown in
Table 1. The study population was similar to the overall hospital population as reported in the Annual Clinical Reports.15
The population studied was predominantly of white European
ethnicity (including Irish) (n = 446, 93.0%(415)) and 30 of the
women reported living in Ireland ≤5 years (n = 388, 7.7%).
One-third (n = 456, 30.5%) reported ﬁnishing in full time education at ≤18 years of age and of the 308 women providing
the relevant information, the rates of relative income poverty and consistent poverty were 23.9% and 4.2%, respectively (Table 1).
Table 2 shows the dietary intakes and vitamin supplements consumption reported by women at their ﬁrst antenatal visit. Despite voluntary food fortiﬁcation, only 2.5% of
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rates were too low.9 Fortiﬁcation alone, however, is not deemed
to be adequate to achieve the desired levels with the continuing
intake of a supplement considered a more reliable method,
especially in women following a low carbohydrate or gluten
free diet.10
There is a dearth of recent information as to what impact
the implementation of public health measures on supplementation and fortiﬁcation with FA have had on development of a macrocytic anaemia during pregnancy particularly
in well-resourced settings. It is notable that in a review of
national guidelines from 20 European countries the focus
was on FA supplementation in the ﬁrst trimester to prevent
NTDs but, no recommendations were made for the rest of
pregnancy to prevent other potential adverse pregnancy outcomes, despite established dietary deﬁciencies of folate in
adult women.8 WHO advises 400 µg of FA supplementation
to continue throughout pregnancy in response to fetomaternal cellular requirements and evidence of dietary deﬁciency.6
In a recent prospective observational study, we found that
women needed to start FA supplementation before they
became pregnant to achieve RBC folate measurements associated with a decreased risk of NTDs.11 In this secondary
analysis we examined the relationship between maternal
intake of both dietary folate and FA supplementation in
early pregnancy with haematological indices both at the ﬁrst
prenatal visit and as pregnancy advanced.
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Table 1 Characteristics of the study population (n = 502)

Table 2 Dietary and supplement intakes and laboratory measurements
of the study population

Characteristic
Dietary intakesa
Age (years) (mean ± SD)

30.7 ± 5.5

BMI (kg/m2) (mean ± SD)

26.0 ± 5.5

Nulliparous (%)

42.6% (n = 214)

Current smokers (%)

12.9% (n = 65)

Obese (%)

19.3% (n = 97)

Median total dietary folate intake (µg) (IQ
range)

235.2 µg (IQ range:
143.6)

Median dietary folate equivalent (µg DFE) (IQ 255.1 µg DFE (IQ range:
range)

185.2)

WHO RNI dietary folate equivalent (µg DFE)

600 µg DFE

White European including Irish

93.0% (n = 415)

Meeting dietary folate recommendations (%)

2.5% (n = 10)

Afro Carribean

1.8% (n = 8)

Meeting folate recommendations (based on

100.0%

Asian

1.4% (n = 6)

Other

dietary and supplemental intake) (%)

3.8% (n = 17)

Median dietary vitamin B12 intake

4.0 µg (IQ range: 2.7)

Finished full time education at ≤18 years (n = 456)

30.5% (n = 139)

WHO RNI for dietary vitamin B12

2.6 µg

Relative income povertya (%) n = 308

23.9% (n = 74)

Meeting dietary vitamin B12

77.3% (n = 303)

Consistent povertya (%)

4.2% (n = 13)

recommendations (%)

Lived in Ireland ≤ 5 years (%) n = 388

7.7% (n = 30)

Median dietary iron intake

GA at ﬁrst visit (weeks) (mean ± SD)

12.5 ± 2.4

EFSA PRI for dietary Iron

27–30 mg

Preterm deliveryb (before 37.0 weeks) (%)

4.0% (19)

Meeting dietary iron recommendations (%)

2.0% (n = 8)

Birth weightb (g) (mean ± SD)

3422.0 ± 573.3

Birth weightb < 2.5 kg (%)

5.2% (26)

Taking folic acid prepregnancy (%)

42.8% (n = 215)

Birth weightb > 4.5 kg (%)

1.8% (9)

Taking folic acid at the ﬁrst antenatal

98.2% (n = 493)

Caesarean deliverya (%)

28.4% (134.0)

9.3 mg (IQ range: 4.4)

Supplement intake

visit (%)
Laboratory measurement (n = 502)

SD, standard deviation; BMI, body mass index; GA, gestational age.

Serum folate (nmol/L) (median, IQ range)

a

Deﬁcient based on serum folate level (%)b

1.0% (n = 5)

Survey on Income and Living Conditions (EU-SILC) 2011.16

Red blood cell folate (nmol/L) (mean, SD)

1137.5 (±443.0)

b

Deﬁcient based on red blood cell folate

0.0%

These measures were based upon questions from the European Union—
Data on delivery outcomes were conﬁned to 472 women as 30 women

levelc

were lost to further follow up and did not deliver in the hospital.

women had a total dietary folate considered adequate for pregnancy. The median total dietary folate intake reported at the
ﬁrst visit (n = 398) was 235.2 µg (interquartile range: 143.6 µg).
At the time of the ﬁrst prenatal visit, 98.2% of women were
taking FA supplementation with only 1.0% deﬁcient based on
red blood cell (RBC) folate level and 0.0% deﬁcient based on
serum folate level. However, 34.3% of women had a RBC folate level below 906 nmol/L (Table 2).
The incidence of anaemia was 1.7% based on a cut-off of
<11.0 g/dL in the 420 women who presented in the ﬁrst trimester. The incidence of anaemia in the women who
attended for their ﬁrst visit in the second trimester (n = 82)
was 2.4% based on a cut-off of <10.5 g/dL. There were 18
cases of anaemia (8.5%) in the 212 women who had a full
blood count taken in the third trimester. Postnatally there
were 89 cases of anaemia based on a cut-off of 10.0 g/dL
(representing 43.4% of the women who had a full blood
count postnatally). There were no cases of macrocytic
anaemia identiﬁed in any trimester or postnatally (Table 3).
Women who were anaemic in the third trimester and
postnatally had lower rates of preconceptual folic acid use

34.6 (IQ range: 18.1)

Red blood cell folate <906 nmol/L (%)d

34.3% (n = 172)

Serum vitamin B12 (pmol/L) (median, IQ

205.0 (IQ range:

range)

110.5)

SD, standard deviation; IQ range, interquartile range; WHO, World Health
Organization; RNI, recommended nutrient intake (per day); EFSA, European
Food Safety Authority; PRI, population reference intake (per day).
a

Dietary intakes reported are based on analysis of the food diaries which

were complete for 398 women in the study cohort.
b

World Health Organization cut off for folate deﬁciency based on serum

folate <6.8 nmol/L.
c

World Health Organization (WHO) cut off for folate deﬁciency based on

red blood cell folate <226.5 nmol/L.
d

The reported threshold concentration for red blood cell folate is reported

as 906 nmol/L by Daly et al.17 Above this concentration, the risk of neural
tube defects (NTDs) was reduced to <8 NTDs/10 000 live births.

compared to those who did not have anaemia (third trimester; FA use in those with anaemia—27.8% versus FA use in
those who were not anaemic—45.6% (not signiﬁcant) and
postnatally; FA use in those with anaemia—43.8% versus
FA use in those who were not anaemic—50.9% (not signiﬁcant)) (Supplementary Table S1).
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Table 3 Full blood count parameters measured in each trimester and postnatally
First trimestera

Second trimestera

Third trimestera

Postnatally

(n = 420)

(n = 82)

(n = 212)

(n = 205)

Mean gestation at phlebotomy (antenatal—weeks, postnatal—days) (±SD)

11.7 (±1.4)

16.6 (±2.4)

39.2 (±1.2)

1.9 (±1.2)

Mean Haemoglobin (g/dL) (±SD)

12.9 (±0.9)

13.0 (±0.8)

12.1 (±1.2)

10.2 (±1.5)

Mean MCV (ﬂ) (±SD)

88.7 (±4.2)

88.7 (±5.8)

87.4 (±5.7)

1.7% (n = 7)

2.4% (n = 2)

8.5% (n = 18)

43.4% (n = 89)

Microcytic anaemiac (%)

0.2% (n = 1)

0.0%

3.8% (n = 8)

8.8% (n = 18)

Macrocytic anaemiac (%)

0.0%

0.0%

0.0%

0.0%

SD, standard deviation; MCV, mean corpuscular volume.
Cut-offs for gestation; ﬁrst trimester <14 weeks, second trimester ≥14 weeks, <28 weeks, third trimester ≥28 weeks. Of the 502 patients, 420 were in

a

their ﬁrst trimester at the time of phlebotomy and 82 were in their second trimester. 212 of the 502 patients had a sample taken in the third trimester
between 37 and 42 weeks.
b

Cut off for anaemia in the ﬁrst trimester; haemoglobin (Hb) <11 g/dL, second and third trimester Hb <10.5 g/dL and postnatal Hb <10.0 g/dL.

Microcytic, MCV < 80 ﬂ; macrocytic, MCV >100 ﬂ.

c

There was a positive relationship identiﬁed between a higher
haemoglobin postnatally and a higher RBC folate level at the
ﬁrst prenatal visit. For women with a Hb > 10.0 g/dL (n =
116) postnatally, the mean RBC folate at the ﬁrst prenatal visit
was 1202.3 (± 444.4) nmol/L compared to a mean RBC folate
of 1060.1 (± 429.1) nmol/L in those with a Hb < 10.0 g/dL
postnatally (P = 0.02) (Supplementary Table S1).
The overall percentage taking FA prepregnancy was
42.8% (Table 2). The use of FA prepregnancy was lower in
those women reporting that they completed full time education at ≤18 years of age (P < 0.001) and amongst those
reporting relative income poverty (P < 0.01). There was no
relationship between prepregnancy FA use and ethnicity or
years lived in Ireland. RBC folate at the ﬁrst prenatal visit
and Hb in the third trimester had a positive relationship
with the prepregnancy use of FA (P < 0.001 and P < 0.005,
respectively). In particular, women who started FA before
pregnancy were more likely to have a higher RBC folate at
the ﬁrst prenatal visit (B: 390.1, 95% CI: 316.9–463.2, P <
0.001), and a higher Hb in the third trimester (B: 0.487, 95%
CI: 0.171–0.804, P = 0.003).
While women who started FA prepregnancy had the same
mean haemoglobin at the ﬁrst prenatal visit compared to
those who did not take prepregnancy FA (12.9 ± 0.8 versus
12.9 ± 0.9 g/dL), they had an increase in their mean haemoglobin in the third trimester (n = 212, 12.3 ± 1.1 versus 11.9 ±
1.2 g/dL, P = 0.003). Multiple regression was performed to
demonstrate the relationship between taking folic acid prepregnancy and a higher haemoglobin in the third trimester.
The relationship between taking FA prepregnancy and Hb
persisted in the third trimester in the ﬁrst model after controlling for age, BMI, current smoking and parity (B: 0.348,

95% CI: 0.010–0.686, P = 0.04). As BMI and smoking status
did not show a signiﬁcant relationship with Hb in the third trimester, they were omitted in the second model (B: 0.361, 95%
CI: 0.028–0.694, P = 0.03) (Table 4).

Discussion
Main ﬁndings of this study

Even with voluntary folate food fortiﬁcation, almost all women
studied (97.5%) had a total dietary folate intake below that
recommended by WHO for pregnancy and breastfeeding,18,19
yet, no woman presenting for prenatal care had a macrocytic
anaemia. The absence of macrocytic anaemia may reﬂect good
compliance with FA supplementation in early pregnancy.
In total, 98.2% were taking FA supplementation at the time
of phlebotomy. However, women who started FA after they
became pregnant had a lower RBC folate at presentation and
were more likely to have a lower Hb in the third trimester. Of
the women who had a FBC postpartum nearly half were
anaemic. This study highlights the potential beneﬁts of women
starting FA before pregnancy and continuing supplementation
throughout pregnancy, even in a developed country, to prevent
maternal anaemia and possibly blood transfusion.
The primary analysis related to this work demonstrated
that the median time of commencement of FA in the group
that took prepregnancy FA (42.8%) was 12 weeks before
pregnancy and in the remaining women, the median duration of commencement was 5 weeks post the last menstrual
period (coinciding with the time point of a positive pregnancy
test).11 It was possible in this analysis to demonstrate that
those who commenced FA ≥ 4 weeks prepregnancy were
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Table 4 Multiple regression analysis showing the relationship between taking folic acid prepregnancy and higher haemoglobin in the third trimester
controlled for maternal age, BMI, smoking status and parity
Variable

Coefﬁcient (B)

SE

95% CI

Pa

Model 1
0.348

0.171

0.010–0.686

0.04

0.034

0.017

0.000–0.068

0.05

Maternal BMI

0.005

0.014

−0.022–0.032

0.71

−0.117

0.265

−0.640–0.407

0.66

0.412

0.176

0.075–0.768

0.02

Smoking status
Nulliparas
Model 2
Folic acid prepregnancy

0.361

0.169

0.028–0.694

0.03

Maternal age

0.036

0.017

0.002–0.069

0.04

Nulliparas

0.407

0.172

0.067–0.747

0.02

SE, standard error; CI, conﬁdence interval; BMI, body mass index.
a

Signiﬁcance value set at 95% level.

more likely to achieve the optimal RBC folate level of >906
nmol/L (86.4 versus 53.3%, P < 0.001).
This study has demonstrated a relationship between use
of FA prepregnancy and a higher haemoglobin in the third
trimester and the relationship persisted upon controlling for
maternal age, BMI, smoking status and parity. Theoretically,
a higher haemoglobin in the third trimester should reduce
the need for blood transfusion due to haemorrhage and
should improve maternal well-being postpartum.
In view of the dietary inadequacies of folate, despite voluntary food fortiﬁcation, our ﬁndings strengthen the case
for women continuing FA supplementation throughout
pregnancy, as recommended by WHO, especially if they only
started during pregnancy.6
Considering the strengths of the study, the hospital provides
care for women from all socioeconomic groups across the
urban-rural divide. All women had sonographic conﬁrmation
of gestational age at the ﬁrst prenatal visit. Clinical and sociodemographic data were computerized at the ﬁrst visit, thus minimizing recall bias. Maternal weight and height were measured
before calculating BMI, and not self-reported at the ﬁrst visit.
Information on dietary intake and supplementation use (including the dose and brand of each supplement) were collected at
the same visit by a SC. Biomarkers were also measured at the
same visit. The laboratory is validated for the analysis of plasma folate, whole blood folate and RBC folate. Pregnancy outcomes were computerized immediately after delivery.

What is already known on this topic

In a study in the USA, for the ﬁrst time, data on the
reported dietary supplement use and folate status among

pregnant women sampled in the National Health and
Nutrition Examination Survey (NHANES) was analysed in
1296 women from 1999 to 2006 after FA food fortiﬁcation
became mandatory.20 When surveyed about taking FA either
as a single or multivitamin in the previous 30 days, only
55–60% reported they consumed FA in the ﬁrst trimester,
76–78% in the second and 88% in the third. The majority
were taking 800 µg as a single supplement. The median RBC
folate was 1255 nmol/L in the ﬁrst trimester and increased
as pregnancy advanced. No information, however, was presented on maternal haematological indices.
A mandatory food fortiﬁcation programme in the USA
has been shown to increase serum folate with a corresponding 19% decline in the incidence of NTDs reported consequently.21,22 A Canadian study based on 95 women of
childbearing age demonstrated that mandatory food fortiﬁcation with FA increased the mean folate consumption by
96 µg/day (within the range predicted by the food fortiﬁcation programme; 70–130 µg/day for adults aged ≥ 19 years).
No one within this cohort met the dietary folate equivalent
for FA without supplementation. Only 14% of women
exceeded the optimal RBC folate of 906 nmol/L associated
with a reduced risk of NTDs.17,23
A systematic review of 31 studies involving 17 771
women examined FA supplementation during pregnancy
and pregnancy outcomes.24 The studies were undertaken
30–45 years previously in both developed and developing
countries using differing dosages of supplementation and
differing deﬁnitions of anaemia. The review found no
impact on the mother of FA before delivery on anaemia
(eight studies), haemoglobin levels (12 studies), serum folate
levels (eight studies) or RBC folate levels (four studies). FA
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What this study adds

Detailed dietary analysis in this study has shown that dietary
folate intakes are inadequate for almost all women. Owing
to supplementation, we have shown that serum and RBC
folate are adequate by the ﬁrst prenatal visit with a positive
correlation between duration of use and these levels. Beyond
the role of folate in preventing NTDs, folate is an integral
vitamin to fetomaternal cellular development throughout pregnancy. We believe this study provides evidence that women
should continue supplementation after the ﬁrst trimester and
postpartum to avoid anaemia and blood transfusion.
Limitations of this study

Limitations of the study include the fact that this study was
undertaken in a country where fortiﬁcation of food with folate is voluntary and not mandatory. Also, we do not have
information as to how many women continued either single
supplementation of FA or iron or multivitamins after the
ﬁrst trimester.

Supplementary data
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